Apeiron Biologics gets regulatory approvals for Phase II Covid-19 trial
Apeiron Biologics has secured approvals from regulatory agencies in Austria, Germany and Denmark to conduct...
Read More...
Focus:
Austria
-
![OncoOne €13m]()
OncoOne launches with €13m Series A funding
Austria-based OncoOne closed its Series A funding round with €13m raised. This financing will be...
Read More...
-
![]()
JOANNEUM RESEARCH
JOANNEUM RESEARCH investigates the pharmacokinetics (PK) and pharmacodynamics (PD) of novel drugs, as well as...
Read More...
-
Deals this week: GlaxoSmithKline, Incyte, Novo Nordisk
GlaxoSmithKline (GSK) and Pfizer have agreed to combine their consumer healthcare businesses with combined annual...
Read More...
-
![anti-infectives platform]()
Sandoz and Ares Genetics partner to develop anti-infectives platform
Novartis division Sandoz has partnered with Ares Genetics to develop a digital anti-infectives platform to...
Read More...
-
![]()
EIB to fund F2G Biotech’s anti-fungal drug research project
The European Investment Bank (EIB) has provided €24m in funding to Austria’s F2G Biotech to...
Read More...
-
![Boehringer Ingelheim’s Biopharmaceutical Production Facility]()
Boehringer Ingelheim’s Biopharmaceutical Production Facility in Vienna, Austria
Germany-based pharmaceutical company Boehringer Ingelheim is constructing a new large-scale cell culture (LSCC) facility at...
Read More...
-
M&As this week: Cambrex Corporation, Boehringer Ingelheim, Supernus Pharmaceuticals
Cambrex Corporation has completed the previously announced acquisition of Halo Pharma (Halo) for $425m.
Read More...
-
Gilead and Hookipa develop new HIV and HBV drugs
Gilead Sciences has partnered with Austria-based biotechnology company Hookipa Biotech to develop new immunotherapies for...
Read More...